Results 181 to 190 of about 16,190 (245)
Some of the next articles are maybe not open access.
Behavioural toxicity of antianxiety and antidepressant agents
Human Psychopharmacology: Clinical and Experimental, 1999Standard measures of psychomotor speed and central nervous system arousal were used to assess the behavioural toxicity of several antianxiety and antidepressant agents. The results indicate that, for the agents evaluated, there is a wide variation in the effects on cognitive function.
openaire +2 more sources
Emerging evidence for antidepressant actions of anesthetic agents
Current Opinion in Anaesthesiology, 2018After decades without substantial advances, multiple novel antidepressants show promise against treatment-resistant depression. Interestingly, many of these are anesthetics. The purpose of this review is to discuss the evidence for the antidepressant effects of ketamine, nitrous oxide, isoflurane and propofol and to consider potential clinical ...
Brian J. Mickey, Scott C Tadler
openaire +3 more sources
GABAmimetics: A New Class of Antidepressant Agents?
Archives of General Psychiatry, 1990To the Editor.— We report a case study of an antidepressant action of progabide, a ɣ-aminobutyric acid (GABA) agonist, in a patient previously unresponsive to other antidepressant drug therapies. To our knowledge, selective GABA agonists have not been previously pursued as antidepressant therapies.
Gunvant K. Thaker +2 more
openaire +2 more sources
Withdrawal Phenomena Associated with Antidepressant and Antipsychotic Agents
Drug Safety, 1994The withdrawal of heterocyclic antidepressants and antipsychotic agents can produce nausea, emesis, anorexia, diarrhoea, rhinorrhoea, diaphoresis, myalgias, paraesthesias, anxiety, agitation, restlessness and insomnia. The withdrawal of monoamine oxidase (MAO) inhibitors may result in severe anxiety, agitation, pressured speech, sleeplessness or ...
openaire +3 more sources
BMJ, 1973 Chapter 1: Antidepressant and Antipsychotic Agents
1976Publisher Summary This chapter focuses on the recent progress in the field of tricyclic antidepressants and the antipsychotic agents. Some of the newer concepts concerning the mechanisms of action of antidepressant and antipsychotic agents are discussed in the chapter.
openaire +2 more sources
Molecular imaging in oncology: Current impact and future directions
Ca-A Cancer Journal for Clinicians, 2022Steven P Rowe, Martin G Pomper
exaly
Chapter 1. Antidepressants and Antipsychotic Agents
1977Publisher Summary This chapter discusses the pharmacological, biochemical, and clinical advances in the area of antidepressant and antipsychotic agents. Synthesis of the tandamine analog containing an N-methyl group produced a compound with strong NE uptake blocking activity as well as a strong potentiator of 5-HTP.
openaire +2 more sources
Treatment of muscle‐invasive and advanced bladder cancer in 2020
Ca-A Cancer Journal for Clinicians, 2020Vaibhav G Patel +2 more
exaly